MPS Pharmaa Limited share price
BSE: ADVIKLA
Key numbers
- Market cap
- ₹ 4.0 Cr
- Current price
- ₹ 2.08
- 52-week high / low
- ₹ 2 / 2
- Stock P/E
- -
- Book value
- ₹ 0.0
- Dividend yield
- 0.00%
- ROCE
- -13.1%
- ROE
- -177.4%
- Debt to equity
- 107.43
- Sales growth (3 yrs)
- -
- Profit growth (3 yrs)
- -
- 1-year return
- 4.5%
About MPS Pharmaa Limited
MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products, such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-C. In addition, the company exports its products to East Asia, Southeast Asia, the Middle East, South America, and Africa. The company was formerly known as Advik Laboratories Limited and changed its name to MPS Pharmaa Limited in December 2022. MPS Pharmaa Limited was incorporated in 1994 and is based in New Delhi, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 |
| Operating profit | -0 | -0 | -0 | -0 | -0 |
| Net profit | -0 | -0 | -0 | -0 | -0 |
| EPS (₹) | -0.12 | -0.12 | -0.12 | -0.19 | -0.12 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.